ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2019 American Transplant Congress

    Induction with Thymoglobulin in DCD Kidneys. Dose Effect and Predictors of Outcome

    A. Asderakis, T. Sabah, A. Jones, E. Ablorsu, L. Szabó, R. Chavez

    Cardiff Transplant Unit, University Hospital of Wales, Cardiff, United Kingdom

    *Purpose: Thymoglobulin (ATG) is used only in few UK centres as induction. We have previously shown good results with ATG for pancreas transplants. The aim…
  • 2019 American Transplant Congress

    Periphery Blood ddcfDNA Can Significantly Differentiate Acute Humoral Rejection from Banff’s Type I Acute Rejection in Kidney Transplantation

    R. Wang1, T. Jiang2, J. Shen1, J. Ge3, W. Lei1, X. Yang3, H. Deng1, W. Kong1, J. Zhou1

    1Kidney Disease Center, First Affiliated Hospital of Zhejiang University, Hangzhou, China, 2Organ diagnosis company, Suzhou, China, 3Organ Diagnosis Company, Suzhou, China

    *Purpose: Cell free DNA(cfDNA) was widely used in field of cancer and obstetric care. Alloantigens was existed in Organ transplantation, so donor derived cfDNA(ddcfDNA) was…
  • 2019 American Transplant Congress

    A Prospective, Randomized, Multicenter Trial of Bela-Based CNI Free and Steroid Withdrawal Immunosuppression: Best Trial Two Year Characterization of Rejection and Renal Function

    A. Wiseman1, A. R. Shields2, R. R. Alloway2, D. Kaufman3, J. P. Leone4, A. J. Matas5, P. West-Thielke6, J. Lipscomb2, E. King2, E. S. Woodle for the BEST Study Group2

    1University of Colorado School of Medicine, Denver, CO, 2University of Cincinnati, Cincinnati, OH, 3University of Wisconsin, Madison, WI, 4Tampa General, Tampa, FL, 5University of Minnesota, Minneapolis, MN, 6University of Illinois, Chicago, Chicago, IL

    *Purpose: The BEST Trial (Belatacept-based Early Steroid Withdrawal Trial) was designed to compare two BELA-based early steroid withdrawal (ESW) regimens with a TAC-based ESW regimen…
  • 2019 American Transplant Congress

    Yellow Fever and Renal Transplantation: Influence of Vaccination and Infection on the Emergence of Antibody-Mediated Rejection

    M. V. Sousa1, R. L. Zollner2, R. S. Stucchi3, I. F. Boin4, E. C. Ataide4, M. Mazzali1

    1Department of Internal Medicine - Division of Nephrology, University of Campinas, Campinas, Brazil, 2Department of Internal Medicine, University of Campinas, Campinas, Brazil, 3Department of Internal Medicine - Division of Infectious Diseases, University of Campinas, Campinas, Brazil, 4Surgery Department, University of Campinas, Campinas, Brazil

    *Purpose: Yellow fever (YF) is a viral hemorrhagic disease transmitted by mosquitos, with variable clinical disease manifestations from a mild, undifferentiated febrile illness to severe…
  • 2019 American Transplant Congress

    Rituximab Desensitization to Liver Transplantaiton Recipients with Preformed Donor Specific Antibodies to Prevent Antibody Mediated Rejecton

    Y. Ogura, M. Shizuku, N. Kurata, K. Jobara, H. Kamei

    Transplantation Surgery, Nagoya University Hospital, Nagoya City, Japan

    *Purpose: Preformed donor-specific antibodies (DSA) are considered as a risk factor after solid organ transplantation. Strong DSA is associated with high mortality and increased risk…
  • 2019 American Transplant Congress

    Role of RIPK3 in Chronic Rejection Following Human Lung Transplantation

    S. Angara, R. Ravichandran, H. Sodawalla, M. Smith, R. Bremner, T. Mohanakumar

    Norton Thoracic Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ

    *Purpose: Immunological mechanisms leading to chronic rejection, bronchiolitis obliterans syndrome (BOS), following human lung transplantation remains unclear though a strong correlation have been identified between…
  • 2019 American Transplant Congress

    Incidence and Risk of Allograft Rejection after Cardiac Transplantation in Left Ventricular Assist Device Patients

    R. C. Patel1, L. B. Cooper2, S. D. Barnett2, R. T. Cole2, M. A. Psotka2, A. Cochrane2, S. Sinha2, L. J. Bogar2, S. S. Desai2, P. Shah2

    1Virginia Commonwealth University School of Medicine, Inova Fairfax Hospital, Falls Church, VA, 2Department of Heart Failure and Transplant, Inova Heart and Vascular Institute, Falls Church, VA

    *Purpose: Left ventricular assist devices (LVAD) are made of biomaterials that have been shown to cause allosensitization. Single center studies have suggested that patients bridged…
  • 2019 American Transplant Congress

    The Evolving Clinical Presentation of Acute Rejection in Face Transplantation

    V. Haug, B. Kollar, D. Obed, H. Kiwanuka, M. Turk, L. Wo, S. Tasigiorgos, M. Kueckelhaus, L. Riella, B. Pomahac

    Plastic and Reconstructive Surgery, Brigham and Women's Hospital, Boston, MA

    *Purpose: Clinical signs such as erythema or edema are traditionally helpful to diagnose Acute rejection (AR) in face transplantation (FT) in the early follow-up. The…
  • 2019 American Transplant Congress

    The Changing Face of T Cell-Mediated Rejection

    A. Perkowska-Ptasinska and INTERCOMEX investigators1, P. F. Halloran2

    1Medical University of Warsaw, Warsaw, Poland, 2Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada

    *Purpose: We studied how the problem of TCMR in indication biopsies was changing with time by exploring features of 138 biopsies with molecular TCMR in…
  • 2019 American Transplant Congress

    The Complexity of T Cell-Mediated Rejection Scenarios: Identifying BK in Biopsies with TCMR

    P. F. Halloran and The INTERCOMEX Investigators1, G. Gupta2, J. Reeve3

    1University of Alberta, Edmonton AB, AB, Canada, 2Virginia Commonwealth University, Richmond, VA, 3Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada

    *Purpose: Some transplanted kidneys have concomitant T cell-mediated rejection (TCMR) and BK virus nephropathy (BK). The histologic diagnosis in BK sometimes overlooks the TCMR component,…
  • « Previous Page
  • 1
  • …
  • 82
  • 83
  • 84
  • 85
  • 86
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences